PT  - JOURNAL ARTICLE
ED  - Velazquez, Eric J.
TI  - No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial
DP  - 2011 Jun 01
TA  - MD Conference Express
PG  - 20--21
VI  - 11
IP  - 3
4099  - http://mdc.sagepub.com/content/11/3/20.short
4100  - http://mdc.sagepub.com/content/11/3/20.full
AB  - Results from the Surgical Treatment of Ischemic Heart Failure STICH trial [NCT00023595] showed no mortality benefit from coronary artery bypass grafting in addition to intensive guideline-based medical therapy compared with medical therapy alone.